GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioInvent International BINV.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

2.95

+18.47%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

9 analysts, 1 Apr 2026. The analysts' own views, not ours.

  • 3Strong buy
  • 5Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 25 Mar 2026. Not our view.

Average target 81.60

Low
60.60
Average
81.60
Median
91.80
High
94.50

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
RevenueSEK 275.6mSEK 786.7mSEK 82.1mSEK 40.0mSEK 40.0m
Revenue, highestSEK 508.4mSEK 1.43bnSEK 129.1mSEK 77.2mSEK 77.2m
Revenue, lowestSEK 42.9mSEK 53.0mSEK 35.2mSEK 4.5mSEK 4.5m
Earnings per share-7.04-5.61-2.25——
Earnings per share, highest-7.04-5.610.35——
Earnings per share, lowest-7.04-5.61-4.97——
Analysts23211

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2023
Forecast-1.94-1.87-1.90-1.11
Reported-1.81-1.87-1.81-1.48
Difference+6.9%0.0%+4.9%-33.6%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

6 / 10

Revenue growth 30.4% a year over 10 years. Return on equity -59.7%.

Piotroski score

4 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.